Loading...
Price History
Market Data
| Market Cap | 4.39B |
| P/E Ratio | - |
| P/B Ratio | 4.15 |
| EPS | -0.17 |
| Dividend Yield | - |
| D/E Ratio | 2.22 |
| Current Ratio | 1.87 |
| Currency | USD |
Key Financial Metrics
1.97B
Revenue
-12.71M
Net Income
-0.17
EPS (Diluted)
460.50M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
3.0%
Net Profit Margin
-0.6%
EBITDA
205.98M
Returns & Efficiency
Return on Assets (ROA)
-0.3%
Return on Equity (ROE)
-1.2%
Dividend Yield
-
EPS
-0.17
Financial Health
Total Assets
3.67B
Total Debt
1.07B
Debt to Equity
2.22x
Current Ratio
1.87
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | LOS ANGELES, CA |
| Fiscal Year | 2024 |
Peers
NATERA, INC.
NTRA
30.11B
P/E: --
21.23B
P/E: --
20.74B
P/E: --
20.74B
P/E: --
12.12B
P/E: --
12.12B
P/E: --
EXACT SCIENCES CORP
EXAS
9.06B
P/E: --
CELCUITY INC.
CELC
7.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$4.39B
P/E Ratio (TTM)-
Price to Book4.15
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin3.0%
Net Margin-0.6%
ROE-1.2%
ROA-0.3%
Leverage & Liquidity
Debt to Equity2.22
Current Ratio1.87
Total Debt$1.07B
Total Assets$3.67B
Stockholders' Equity$1.06B
Income Statement (FY 2024)
Revenue$1.97B
Gross Profit-
Operating Income$58.69M
Net Income$-12.71M
EPS (Diluted)$-0.17
Cash Flow (FY 2024)
Free Cash Flow$460.50M
Cash & Equivalents$804.72M
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 1510 COTNER AVE LOS ANGELES, CA 90025 |
| Phone | 3104787808 |
| Incorporated | DE, US |
| EIN | 133326724 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 75.95M |
| Stockholders' Equity | $1.06B |
| Cash & Equivalents | $804.72M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-20
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-20
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-20
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-19
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-18
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | RADNET, INC. |
| Ticker | RDNT |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | LOS ANGELES, CA |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 4.39B |
| Revenue | 1.97B |
| Net Income | -12.71M |
| P/E Ratio | - |
| EPS | -0.17 |
| Net Margin | -0.6% |
| ROE | -1.2% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...